ClinicalTrials HQ

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Active, not recruiting · NCT06799247 · Registry updated 2026-09-01
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisNeoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndromeActive, not recruitingPhase 32026-09-01NCT06799247

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Cartesian Therapeutics5

34 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
A10TampaUnited States1
A11PhiladelphiaUnited States1
A12AmherstUnited States1
A13CarlsbadUnited States1
A14OrangeUnited States1
A15PortlandUnited States1
A16LexingtonUnited States1
A17IstanbulTurkey (Türkiye)1
A18TorontoCanada1
A20FairwayUnited States1
A21AuroraUnited States1
A22Chapel HillUnited States1
A23RomeItaly1
A24BelgradeSerbia1
A25BarcelonaSpain1
A26BarcelonaSpain1
A30KrakowPoland1
A31MadridSpain1
A32AnkaraTurkey (Türkiye)1
A33BirminghamUnited Kingdom1
A38BostonUnited States1
A39CharlotteUnited States1
A40TucsonUnited States1
A41SeattleUnited States1
A43HoustonUnited States1